Bernstein DI - Search Results

1

Topical SMIP-7.7, a toll-like receptor 7 agonist, protects against genital herpes simplex virus type-2 disease in the guinea pig model of genital herpes.

Bernstein DI, Cardin RD, Bravo FJ, Earwood J, Clark JR, Li Y, Mishra P, Li C, Nayak BP, Miller AT, Wu TY, Cooke MP, Valiante NM. Bernstein DI, et al. Antivir Chem Chemother. 2014 Apr 11;23(5):189-96. doi: 10.3851/IMP2499. Antivir Chem Chemother. 2014. PMID: 23232327 Free article.

2

Modification of primary and recurrent genital herpes in guinea pigs by passive immunization.

Bourne N, Pyles RB, Bernstein DI, Stanberry LR. Bourne N, et al. Among authors: bernstein di. J Gen Virol. 2002 Nov;83(Pt 11):2797-2801. doi: 10.1099/0022-1317-83-11-2797. J Gen Virol. 2002. PMID: 12388816

3

Quantitative-competitive PCR monitoring of viral load following experimental guinea pig cytomegalovirus infection.

Schleiss MR, Bourne N, Bravo FJ, Jensen NJ, Bernstein DI. Schleiss MR, et al. Among authors: bernstein di. J Virol Methods. 2003 Mar;108(1):103-10. doi: 10.1016/s0166-0934(02)00265-3. J Virol Methods. 2003. PMID: 12565160

4

Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.

Bourne N, Bravo FJ, Francotte M, Bernstein DI, Myers MG, Slaoui M, Stanberry LR. Bourne N, et al. Among authors: bernstein di. J Infect Dis. 2003 Feb 15;187(4):542-9. doi: 10.1086/374002. Epub 2003 Feb 7. J Infect Dis. 2003. PMID: 12599070

5

An animal model of neonatal cytomegalovirus infection.

Bravo FJ, Bourne N, Schleiss MR, Bernstein DI. Bravo FJ, et al. Among authors: bernstein di. Antiviral Res. 2003 Sep;60(1):41-9. doi: 10.1016/s0166-3542(03)00151-7. Antiviral Res. 2003. PMID: 14516920

6

Treatment of herpes simplex virus infections.

Brady RC, Bernstein DI. Brady RC, et al. Among authors: bernstein di. Antiviral Res. 2004 Feb;61(2):73-81. doi: 10.1016/j.antiviral.2003.09.006. Antiviral Res. 2004. PMID: 14670580 Review.

7

Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection.

Schleiss MR, Bourne N, Bernstein DI. Schleiss MR, et al. Among authors: bernstein di. J Infect Dis. 2003 Dec 15;188(12):1868-74. doi: 10.1086/379839. Epub 2003 Dec 9. J Infect Dis. 2003. PMID: 14673766

8

Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine.

Schleiss MR, Bourne N, Stroup G, Bravo FJ, Jensen NJ, Bernstein DI. Schleiss MR, et al. Among authors: bernstein di. J Infect Dis. 2004 Apr 15;189(8):1374-81. doi: 10.1086/382751. Epub 2004 Apr 1. J Infect Dis. 2004. PMID: 15073673

9

Longitudinal risk of herpes simplex virus (HSV) type 1, HSV type 2, and cytomegalovirus infections among young adolescent girls.

Stanberry LR, Rosenthal SL, Mills L, Succop PA, Biro FM, Morrow RA, Bernstein DI. Stanberry LR, et al. Among authors: bernstein di. Clin Infect Dis. 2004 Nov 15;39(10):1433-8. doi: 10.1086/425307. Epub 2004 Oct 25. Clin Infect Dis. 2004. PMID: 15546077

10

The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs.

Schleiss MR, Bernstein DI, McVoy MA, Stroup G, Bravo F, Creasy B, McGregor A, Henninger K, Hallenberger S. Schleiss MR, et al. Among authors: bernstein di. Antiviral Res. 2005 Jan;65(1):35-43. doi: 10.1016/j.antiviral.2004.09.004. Antiviral Res. 2005. PMID: 15652969 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

600 results

Search Page

Filters